Frederick, Maryland -- Biotechnology company Akonni Biosystems has raised $800,000 in venture capital debt funding, according to an SEC regulatory filing.
Akonni is developing and marketing integrated molecular diagnostics systems.
Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.
A total of four investors participated in the offering.
Akonni is still seeking $4.2 million in additional financing, according to the filing.
Minimum investment size per investor was listed as $25,000.